Renin–angiotensin–system inhibitors and the risk of exacerbations in chronic obstructive pulmonary disease: a nationwide registry study

Renin–angiotensin–system inhibitors and the risk of exacerbations in chronic obstructive pulmonary disease: a nationwide registry study

Objective The renin–angiotensin system (RAS) has been shown to play a role in the pathogenesis of chronic obstructive pulmonary disease (COPD) because of the inflammatory properties of the system. Many patients with COPD use RAS-inhibiting (RASi) treatment. The aim was to determine the association b...

Full description

Bibliographic Details
Main Authors: Pradeesh Sivapalan, Rikke Sørensen, Josefin Eklöf, Jens-Ulrik Stæhr Jensen, Tor Biering-Sørensen, Lars Pedersen, Ole Hilberg, Tobias Wirenfeldt Klausen, Caroline Hedsund, Frida Vilstrup, Christian Kjer Heerfordt, Peter Kamstrup, Shailesh Kolekar, Thomas Kromann Lund, Kristoffer Grundtvig Skaarup
Format: Article
Language:English
Published: BMJ Publishing Group 2023-07-01
Series:BMJ Open Respiratory Research
Online Access:https://bmjopenrespres.bmj.com/content/10/1/e001428.full

Internet

https://bmjopenrespres.bmj.com/content/10/1/e001428.full

Similar Items